Eric Scott Rosenthal, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Status Epilepticus | 16 | 2024 | 463 | 3.380 |
Why?
|
Subarachnoid Hemorrhage | 15 | 2024 | 1039 | 3.000 |
Why?
|
Electroencephalography | 37 | 2024 | 6317 | 2.490 |
Why?
|
Brain Ischemia | 11 | 2022 | 3008 | 1.800 |
Why?
|
Critical Care | 16 | 2024 | 2716 | 1.790 |
Why?
|
Seizures | 21 | 2024 | 3000 | 1.670 |
Why?
|
Brain Injuries | 8 | 2024 | 2059 | 1.030 |
Why?
|
Anticonvulsants | 8 | 2024 | 1923 | 1.030 |
Why?
|
Monitoring, Physiologic | 10 | 2024 | 1795 | 0.930 |
Why?
|
Intensive Care Units | 13 | 2024 | 3801 | 0.880 |
Why?
|
Fluorodeoxyglucose F18 | 3 | 2020 | 2056 | 0.690 |
Why?
|
Phenytoin | 1 | 2020 | 190 | 0.670 |
Why?
|
Cerebral Infarction | 3 | 2022 | 975 | 0.570 |
Why?
|
Pregnanolone | 1 | 2017 | 67 | 0.560 |
Why?
|
Health Occupations | 1 | 2018 | 225 | 0.540 |
Why?
|
Anesthetics | 1 | 2020 | 525 | 0.460 |
Why?
|
Infectious Disease Incubation Period | 1 | 2014 | 16 | 0.460 |
Why?
|
Neurology | 2 | 2020 | 786 | 0.440 |
Why?
|
Nervous System Diseases | 2 | 2022 | 1664 | 0.440 |
Why?
|
Rabies | 1 | 2014 | 56 | 0.440 |
Why?
|
Intubation, Intratracheal | 1 | 2021 | 1359 | 0.410 |
Why?
|
Positron-Emission Tomography | 3 | 2020 | 6670 | 0.400 |
Why?
|
Consciousness Disorders | 5 | 2023 | 445 | 0.400 |
Why?
|
Coma | 6 | 2023 | 487 | 0.390 |
Why?
|
Models, Neurological | 1 | 2020 | 1783 | 0.380 |
Why?
|
Neurophysiology | 1 | 2012 | 145 | 0.370 |
Why?
|
Recovery of Function | 1 | 2021 | 2990 | 0.350 |
Why?
|
Intracranial Pressure | 2 | 2024 | 325 | 0.350 |
Why?
|
Evoked Potentials, Somatosensory | 1 | 2012 | 247 | 0.350 |
Why?
|
Critical Illness | 8 | 2024 | 2755 | 0.340 |
Why?
|
Cortical Spreading Depression | 3 | 2020 | 288 | 0.330 |
Why?
|
Venous Thromboembolism | 1 | 2022 | 1881 | 0.320 |
Why?
|
Consciousness | 3 | 2020 | 602 | 0.320 |
Why?
|
Propofol | 3 | 2024 | 608 | 0.300 |
Why?
|
Humans | 92 | 2024 | 768393 | 0.290 |
Why?
|
Consensus | 2 | 2023 | 3212 | 0.290 |
Why?
|
Central Nervous System Diseases | 1 | 2012 | 523 | 0.280 |
Why?
|
Radiopharmaceuticals | 2 | 2019 | 2734 | 0.280 |
Why?
|
Emigrants and Immigrants | 1 | 2014 | 549 | 0.280 |
Why?
|
Quality Assurance, Health Care | 2 | 2016 | 2181 | 0.270 |
Why?
|
Scalp | 2 | 2022 | 391 | 0.260 |
Why?
|
Phylogeny | 1 | 2014 | 2843 | 0.260 |
Why?
|
Aged | 36 | 2024 | 171562 | 0.250 |
Why?
|
Glasgow Outcome Scale | 4 | 2018 | 104 | 0.250 |
Why?
|
Cerebral Angiography | 2 | 2008 | 1274 | 0.250 |
Why?
|
Middle Aged | 41 | 2024 | 223491 | 0.240 |
Why?
|
Retrospective Studies | 31 | 2024 | 81801 | 0.240 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2008 | 485 | 0.240 |
Why?
|
Pilot Projects | 6 | 2024 | 8731 | 0.240 |
Why?
|
Adult | 38 | 2024 | 223640 | 0.220 |
Why?
|
Early Diagnosis | 3 | 2017 | 1195 | 0.210 |
Why?
|
Brain | 10 | 2022 | 27454 | 0.210 |
Why?
|
Life Support Care | 1 | 2024 | 226 | 0.200 |
Why?
|
Intermittent Pneumatic Compression Devices | 1 | 2022 | 28 | 0.200 |
Why?
|
Thrombolytic Therapy | 4 | 2020 | 2050 | 0.200 |
Why?
|
Male | 43 | 2024 | 364902 | 0.200 |
Why?
|
Conscious Sedation | 2 | 2016 | 534 | 0.190 |
Why?
|
Persistent Vegetative State | 3 | 2020 | 275 | 0.190 |
Why?
|
Young Adult | 17 | 2021 | 60049 | 0.190 |
Why?
|
Brain Waves | 2 | 2017 | 418 | 0.190 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2008 | 1226 | 0.190 |
Why?
|
Female | 43 | 2024 | 397089 | 0.180 |
Why?
|
Vasoconstrictor Agents | 1 | 2024 | 657 | 0.180 |
Why?
|
Heart Rate | 3 | 2017 | 4218 | 0.180 |
Why?
|
Tissue Plasminogen Activator | 4 | 2009 | 1163 | 0.180 |
Why?
|
Implantable Neurostimulators | 1 | 2021 | 75 | 0.180 |
Why?
|
Withholding Treatment | 1 | 2024 | 620 | 0.170 |
Why?
|
Cohort Studies | 13 | 2024 | 41795 | 0.170 |
Why?
|
Automation | 3 | 2017 | 588 | 0.170 |
Why?
|
Practice Guidelines as Topic | 2 | 2016 | 7453 | 0.170 |
Why?
|
Hypoalbuminemia | 1 | 2020 | 90 | 0.170 |
Why?
|
Vasospasm, Intracranial | 1 | 2021 | 214 | 0.160 |
Why?
|
Epilepsy | 3 | 2023 | 3326 | 0.160 |
Why?
|
Cerebrovascular Circulation | 4 | 2016 | 2736 | 0.150 |
Why?
|
Benzodiazepines | 2 | 2023 | 1139 | 0.150 |
Why?
|
Epilepsy, Post-Traumatic | 1 | 2018 | 40 | 0.150 |
Why?
|
Solubility | 1 | 2020 | 1085 | 0.150 |
Why?
|
Hospitals | 2 | 2022 | 3906 | 0.150 |
Why?
|
Shock, Septic | 1 | 2024 | 774 | 0.150 |
Why?
|
Blood Coagulation Factors | 1 | 2020 | 366 | 0.150 |
Why?
|
Valproic Acid | 1 | 2020 | 443 | 0.140 |
Why?
|
Out-of-Hospital Cardiac Arrest | 1 | 2022 | 340 | 0.140 |
Why?
|
Brain Edema | 1 | 2022 | 607 | 0.140 |
Why?
|
Prospective Studies | 10 | 2024 | 54920 | 0.140 |
Why?
|
Ventilator-Induced Lung Injury | 1 | 2018 | 135 | 0.140 |
Why?
|
Anterior Temporal Lobectomy | 1 | 2016 | 46 | 0.140 |
Why?
|
Aged, 80 and over | 13 | 2024 | 59686 | 0.140 |
Why?
|
Ketamine | 1 | 2023 | 525 | 0.140 |
Why?
|
Encephalitis, Herpes Simplex | 1 | 2016 | 65 | 0.130 |
Why?
|
Neuroprotective Agents | 1 | 2023 | 957 | 0.130 |
Why?
|
Sentinel Surveillance | 1 | 2018 | 292 | 0.130 |
Why?
|
Ventilators, Mechanical | 1 | 2018 | 292 | 0.130 |
Why?
|
Anesthetics, Intravenous | 1 | 2018 | 397 | 0.130 |
Why?
|
Glasgow Coma Scale | 3 | 2024 | 580 | 0.120 |
Why?
|
Clinical Competence | 2 | 2023 | 4848 | 0.120 |
Why?
|
Emergencies | 1 | 2022 | 1219 | 0.120 |
Why?
|
Nerve Net | 2 | 2018 | 2362 | 0.120 |
Why?
|
Electric Stimulation Therapy | 1 | 2021 | 636 | 0.120 |
Why?
|
Tomography, X-Ray Computed | 3 | 2024 | 20765 | 0.120 |
Why?
|
Sensitivity and Specificity | 6 | 2018 | 14737 | 0.120 |
Why?
|
Intracranial Hemorrhages | 2 | 2020 | 811 | 0.120 |
Why?
|
Electronic Health Records | 3 | 2022 | 4875 | 0.110 |
Why?
|
Drug Monitoring | 1 | 2020 | 964 | 0.110 |
Why?
|
Residence Characteristics | 1 | 2024 | 2122 | 0.110 |
Why?
|
Psychomotor Agitation | 1 | 2016 | 307 | 0.110 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2022 | 997 | 0.110 |
Why?
|
Language | 2 | 2020 | 1558 | 0.110 |
Why?
|
Finite Element Analysis | 1 | 2016 | 442 | 0.110 |
Why?
|
Heart Arrest | 1 | 2023 | 1516 | 0.110 |
Why?
|
Hospital Mortality | 2 | 2024 | 5367 | 0.110 |
Why?
|
Lamivudine | 1 | 2015 | 367 | 0.110 |
Why?
|
Massachusetts | 2 | 2024 | 8902 | 0.110 |
Why?
|
Hypnotics and Sedatives | 2 | 2023 | 1188 | 0.110 |
Why?
|
Treatment Outcome | 14 | 2024 | 65379 | 0.110 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2017 | 1496 | 0.100 |
Why?
|
Adolescent | 10 | 2022 | 89184 | 0.100 |
Why?
|
Cost of Illness | 1 | 2021 | 1959 | 0.090 |
Why?
|
Hepatitis B, Chronic | 1 | 2015 | 413 | 0.090 |
Why?
|
Artificial Intelligence | 2 | 2023 | 2661 | 0.090 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2014 | 359 | 0.090 |
Why?
|
Sports | 1 | 2016 | 703 | 0.090 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2017 | 862 | 0.080 |
Why?
|
Magnetic Resonance Angiography | 1 | 2016 | 1434 | 0.080 |
Why?
|
Brazil | 1 | 2014 | 1248 | 0.080 |
Why?
|
Biomedical Research | 2 | 2023 | 3464 | 0.080 |
Why?
|
Prognosis | 7 | 2024 | 30022 | 0.080 |
Why?
|
Respiration, Artificial | 2 | 2020 | 2721 | 0.080 |
Why?
|
Aortic Coarctation | 1 | 2011 | 278 | 0.080 |
Why?
|
Septal Occluder Device | 1 | 2010 | 125 | 0.080 |
Why?
|
Cross Infection | 1 | 2018 | 1426 | 0.080 |
Why?
|
Stroke | 5 | 2019 | 9742 | 0.080 |
Why?
|
Dogs | 1 | 2014 | 3846 | 0.080 |
Why?
|
Cerebral Cortex | 2 | 2016 | 5831 | 0.080 |
Why?
|
Hypothermia, Induced | 1 | 2014 | 756 | 0.080 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2010 | 353 | 0.080 |
Why?
|
Reference Standards | 2 | 2023 | 1013 | 0.080 |
Why?
|
Inpatients | 1 | 2020 | 2570 | 0.080 |
Why?
|
Brain Diseases | 1 | 2017 | 1552 | 0.070 |
Why?
|
Angioplasty, Balloon | 1 | 2011 | 592 | 0.070 |
Why?
|
Brain Infarction | 1 | 2009 | 288 | 0.070 |
Why?
|
Recurrence | 2 | 2017 | 8506 | 0.070 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2010 | 452 | 0.070 |
Why?
|
Glucose | 1 | 2019 | 4352 | 0.070 |
Why?
|
Electrocardiography | 2 | 2017 | 6409 | 0.070 |
Why?
|
Infusions, Intravenous | 3 | 2024 | 2226 | 0.070 |
Why?
|
Reproducibility of Results | 5 | 2023 | 20224 | 0.070 |
Why?
|
Education, Medical | 1 | 2018 | 1742 | 0.070 |
Why?
|
Remote Consultation | 2 | 2009 | 242 | 0.070 |
Why?
|
Child | 6 | 2023 | 80891 | 0.070 |
Why?
|
Demography | 2 | 2024 | 1642 | 0.070 |
Why?
|
Telephone | 1 | 2009 | 630 | 0.070 |
Why?
|
Fibrinolytic Agents | 2 | 2005 | 2074 | 0.060 |
Why?
|
Brain Concussion | 1 | 2016 | 1433 | 0.060 |
Why?
|
ROC Curve | 3 | 2017 | 3623 | 0.060 |
Why?
|
Data Collection | 1 | 2012 | 3324 | 0.050 |
Why?
|
Decision Support Techniques | 1 | 2013 | 2006 | 0.050 |
Why?
|
Patient Transfer | 1 | 2009 | 793 | 0.050 |
Why?
|
Antiviral Agents | 1 | 2015 | 3064 | 0.050 |
Why?
|
Videoconferencing | 1 | 2004 | 209 | 0.050 |
Why?
|
Disease Management | 1 | 2013 | 2537 | 0.050 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2016 | 2820 | 0.050 |
Why?
|
Referral and Consultation | 1 | 2014 | 3627 | 0.050 |
Why?
|
Ultrasonography, Interventional | 1 | 2010 | 1525 | 0.050 |
Why?
|
Epilepsia Partialis Continua | 1 | 2021 | 25 | 0.050 |
Why?
|
Arterial Occlusive Diseases | 1 | 2005 | 746 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2024 | 10776 | 0.040 |
Why?
|
Sialic Acids | 1 | 2000 | 123 | 0.040 |
Why?
|
Neural Cell Adhesion Molecule L1 | 1 | 2000 | 44 | 0.040 |
Why?
|
Neural Cell Adhesion Molecules | 1 | 2000 | 122 | 0.040 |
Why?
|
Lorazepam | 1 | 2021 | 155 | 0.040 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2021 | 279 | 0.040 |
Why?
|
Diazepam | 1 | 2021 | 214 | 0.040 |
Why?
|
Time Factors | 5 | 2014 | 40272 | 0.040 |
Why?
|
Gliosis | 1 | 2000 | 246 | 0.040 |
Why?
|
Delphi Technique | 1 | 2023 | 888 | 0.040 |
Why?
|
Risk Assessment | 6 | 2023 | 24318 | 0.040 |
Why?
|
Stents | 1 | 2011 | 3201 | 0.040 |
Why?
|
Midazolam | 1 | 2021 | 267 | 0.040 |
Why?
|
Factor Xa | 1 | 2020 | 166 | 0.040 |
Why?
|
Infection Control Practitioners | 1 | 2018 | 12 | 0.040 |
Why?
|
Substantia Nigra | 1 | 2000 | 348 | 0.040 |
Why?
|
Posterior Leukoencephalopathy Syndrome | 1 | 2019 | 50 | 0.040 |
Why?
|
Mass Screening | 1 | 2014 | 5451 | 0.040 |
Why?
|
Cerebral Hemorrhage | 2 | 2009 | 2653 | 0.040 |
Why?
|
Artifacts | 2 | 2017 | 1930 | 0.040 |
Why?
|
Migraine with Aura | 1 | 2020 | 204 | 0.040 |
Why?
|
Feasibility Studies | 3 | 2016 | 5313 | 0.030 |
Why?
|
Ischemia | 1 | 2005 | 1900 | 0.030 |
Why?
|
Databases, Factual | 1 | 2012 | 8075 | 0.030 |
Why?
|
Imagination | 1 | 2017 | 226 | 0.030 |
Why?
|
Advisory Committees | 1 | 2020 | 797 | 0.030 |
Why?
|
Periodicity | 1 | 2017 | 348 | 0.030 |
Why?
|
Thrombectomy | 1 | 2020 | 671 | 0.030 |
Why?
|
Intensive Care, Neonatal | 1 | 2017 | 200 | 0.030 |
Why?
|
Spin Labels | 1 | 2016 | 339 | 0.030 |
Why?
|
Epilepsies, Partial | 1 | 2019 | 435 | 0.030 |
Why?
|
Pyridones | 1 | 2020 | 818 | 0.030 |
Why?
|
Music | 1 | 2017 | 247 | 0.030 |
Why?
|
Algorithms | 3 | 2022 | 14154 | 0.030 |
Why?
|
Corpus Striatum | 1 | 2000 | 1237 | 0.030 |
Why?
|
HIV Seronegativity | 1 | 2015 | 210 | 0.030 |
Why?
|
Risk Factors | 1 | 2021 | 74962 | 0.030 |
Why?
|
Hepatitis B Surface Antigens | 1 | 2015 | 294 | 0.030 |
Why?
|
Guanine | 1 | 2015 | 280 | 0.030 |
Why?
|
France | 1 | 2015 | 497 | 0.030 |
Why?
|
Emergency Service, Hospital | 3 | 2022 | 7955 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2020 | 2728 | 0.030 |
Why?
|
Software | 2 | 2018 | 4453 | 0.030 |
Why?
|
Terminology as Topic | 1 | 2020 | 1539 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 4 | 2023 | 36849 | 0.030 |
Why?
|
Astrocytes | 1 | 2000 | 1349 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2009 | 9063 | 0.020 |
Why?
|
Patient Discharge | 2 | 2018 | 3476 | 0.020 |
Why?
|
Spectrum Analysis | 1 | 2014 | 449 | 0.020 |
Why?
|
Telemedicine | 1 | 2009 | 3107 | 0.020 |
Why?
|
Electric Impedance | 1 | 2016 | 795 | 0.020 |
Why?
|
London | 1 | 2011 | 233 | 0.020 |
Why?
|
Acute Disease | 1 | 2022 | 7242 | 0.020 |
Why?
|
Neurologic Examination | 1 | 2014 | 916 | 0.020 |
Why?
|
Predictive Value of Tests | 3 | 2017 | 15455 | 0.020 |
Why?
|
Severity of Illness Index | 4 | 2013 | 15939 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2020 | 6510 | 0.020 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2015 | 710 | 0.020 |
Why?
|
Retreatment | 1 | 2011 | 600 | 0.020 |
Why?
|
Pyrazoles | 1 | 2020 | 2021 | 0.020 |
Why?
|
Animals | 4 | 2020 | 169337 | 0.020 |
Why?
|
HIV Seropositivity | 1 | 2015 | 962 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2015 | 2862 | 0.020 |
Why?
|
Research Design | 1 | 2024 | 6210 | 0.020 |
Why?
|
HIV Infections | 1 | 2015 | 17575 | 0.020 |
Why?
|
Intracranial Aneurysm | 1 | 2018 | 1293 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2018 | 2783 | 0.020 |
Why?
|
Reference Values | 1 | 2015 | 4941 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2024 | 10377 | 0.020 |
Why?
|
Cerebral Arteries | 1 | 2009 | 489 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2015 | 2353 | 0.020 |
Why?
|
Computational Biology | 1 | 2018 | 3543 | 0.020 |
Why?
|
United States | 1 | 2014 | 73150 | 0.020 |
Why?
|
Patient Admission | 1 | 2012 | 1367 | 0.010 |
Why?
|
Catheterization | 1 | 2010 | 1431 | 0.010 |
Why?
|
Follow-Up Studies | 3 | 2011 | 39407 | 0.010 |
Why?
|
Basilar Artery | 1 | 2005 | 207 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 8051 | 0.010 |
Why?
|
Liver Cirrhosis | 1 | 2015 | 1959 | 0.010 |
Why?
|
Prosthesis Design | 1 | 2011 | 2126 | 0.010 |
Why?
|
Risk | 1 | 2016 | 9636 | 0.010 |
Why?
|
Age Factors | 1 | 2021 | 18471 | 0.010 |
Why?
|
Middle Cerebral Artery | 1 | 2005 | 273 | 0.010 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2009 | 953 | 0.010 |
Why?
|
Models, Statistical | 1 | 2018 | 5099 | 0.010 |
Why?
|
Survival Analysis | 1 | 2015 | 10117 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2018 | 14784 | 0.010 |
Why?
|
Antihypertensive Agents | 1 | 2011 | 2027 | 0.010 |
Why?
|
Dementia | 1 | 2016 | 2729 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2015 | 12092 | 0.010 |
Why?
|
Sympatholytics | 1 | 2000 | 82 | 0.010 |
Why?
|
Hematoma | 1 | 2005 | 768 | 0.010 |
Why?
|
Oxidopamine | 1 | 2000 | 173 | 0.010 |
Why?
|
Angiography | 1 | 2005 | 1598 | 0.010 |
Why?
|
Comorbidity | 1 | 2015 | 10588 | 0.010 |
Why?
|
Logistic Models | 1 | 2015 | 13323 | 0.010 |
Why?
|
Denervation | 1 | 2000 | 265 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2017 | 22296 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2015 | 4365 | 0.010 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2000 | 559 | 0.010 |
Why?
|
Length of Stay | 1 | 2012 | 6519 | 0.010 |
Why?
|
Disease Progression | 1 | 2015 | 13646 | 0.010 |
Why?
|
Proteoglycans | 1 | 2000 | 807 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2017 | 26411 | 0.010 |
Why?
|
Regression Analysis | 1 | 2005 | 6350 | 0.010 |
Why?
|
Computer Simulation | 1 | 2009 | 6277 | 0.010 |
Why?
|
Blood Pressure | 1 | 2011 | 8541 | 0.010 |
Why?
|
Emergency Medicine | 1 | 2004 | 1222 | 0.010 |
Why?
|
Antigens | 1 | 2000 | 1443 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2009 | 13020 | 0.010 |
Why?
|
Dopamine | 1 | 2000 | 1617 | 0.010 |
Why?
|
Quality of Life | 1 | 2013 | 13503 | 0.010 |
Why?
|
Hospitalization | 1 | 2009 | 10844 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2000 | 8199 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2010 | 15881 | 0.000 |
Why?
|
Child, Preschool | 1 | 2010 | 42650 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 2000 | 11120 | 0.000 |
Why?
|
Cells, Cultured | 1 | 2000 | 19022 | 0.000 |
Why?
|
Rats | 1 | 2000 | 23835 | 0.000 |
Why?
|